{
  "id": 5663275,
  "title": "Is HCA Healthcare Stock Underperforming the Nasdaq?",
  "url": "https://urgent.news/2026/09/03/is-hca-healthcare-stock-underperforming-the-nasdaq",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-03T15:52:37.000Z",
  "source": {
    "name": "Yahoo Finance",
    "slug": "yahoo-finance",
    "url": "https://finance.yahoo.com/markets/stocks/articles/hca-healthcare-stock-underperforming-nasdaq-155237603.html"
  },
  "original_language": "en",
  "account": "HCA Healthcare, headquartered in Nashville, Tennessee, is a large-cap company valued at $87 billion, specializing in healthcare services and education. The company has a diversified portfolio, attracting patients in high-growth states like Florida, Texas, and Tennessee. Despite its market leadership, HCA's stock has underperformed the Nasdaq Composite index over the past year, slipping 27% from its 52-week high. The decline can be attributed to a worsening payer mix, as many individuals lost coverage through health insurance exchanges following the expiration of Affordable Care Act subsidies. This shift towards uninsured or underinsured patients led to a decline in high-margin surgeries, negatively impacting reimbursement rates. While HCA stock has fallen 13.2% year-to-date, the Nasdaq Composite has gained 1.6%. HCA's management has already revised its full-year EPS guidance downwards, to a range of $28.70 to $30.50. Despite these challenges, Wall Street analysts remain cautiously optimistic about HCA's future, giving the stock a \"Moderate Buy\" rating and a mean price target of $455.05, representing a potential 12% upside from current levels.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}